| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.87e-06 | 109 | 23 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.38e-05 | 49 | 23 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 4.74e-05 | 178 | 23 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.32e-05 | 614 | 23 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 6.89e-05 | 196 | 23 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.24e-04 | 441 | 23 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.92e-04 | 18 | 23 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 3.45e-04 | 24 | 23 | 2 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 3.75e-04 | 25 | 23 | 2 | GO:0120015 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.71e-04 | 28 | 23 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.38e-04 | 35 | 23 | 2 | GO:0015020 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.25e-04 | 37 | 23 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.63e-03 | 775 | 23 | 5 | GO:0017111 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 1.95e-03 | 57 | 23 | 2 | GO:0120013 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.99e-03 | 477 | 23 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.32e-03 | 839 | 23 | 5 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.33e-03 | 840 | 23 | 5 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.33e-03 | 840 | 23 | 5 | GO:0016818 | |
| GeneOntologyMolecularFunction | transporter activity | 2.78e-03 | 1289 | 23 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.92e-03 | 70 | 23 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.92e-03 | 70 | 23 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.17e-03 | 73 | 23 | 2 | GO:0170055 | |
| GeneOntologyMolecularFunction | antioxidant activity | 5.53e-03 | 97 | 23 | 2 | GO:0016209 | |
| GeneOntologyMolecularFunction | hormone binding | 6.21e-03 | 103 | 23 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.08e-03 | 118 | 23 | 2 | GO:0003774 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 9.85e-03 | 1180 | 23 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.33e-02 | 153 | 23 | 2 | GO:0008194 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.14e-06 | 525 | 23 | 7 | GO:0009410 | |
| GeneOntologyBiologicalProcess | response to progesterone | 1.67e-05 | 45 | 23 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 3.32e-05 | 8 | 23 | 2 | GO:0070980 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 3.98e-05 | 358 | 23 | 5 | GO:0015850 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 5.32e-05 | 10 | 23 | 2 | GO:0018879 | |
| GeneOntologyBiologicalProcess | cellular hypotonic response | 7.80e-05 | 12 | 23 | 2 | GO:0071476 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 7.80e-05 | 12 | 23 | 2 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 8.10e-05 | 684 | 23 | 6 | GO:0010817 | |
| GeneOntologyBiologicalProcess | hypotonic response | 1.07e-04 | 14 | 23 | 2 | GO:0006971 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.47e-04 | 21 | 23 | 2 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.60e-04 | 286 | 23 | 4 | GO:0042445 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.80e-04 | 26 | 23 | 2 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.80e-04 | 26 | 23 | 2 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 5.01e-04 | 141 | 23 | 3 | GO:0006805 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 7.74e-04 | 37 | 23 | 2 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.74e-04 | 37 | 23 | 2 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.16e-04 | 38 | 23 | 2 | GO:0008209 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.60e-04 | 487 | 23 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.42e-04 | 25 | 23 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | apical part of cell | 3.95e-04 | 592 | 23 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 8.81e-04 | 40 | 23 | 2 | GO:0005640 | |
| GeneOntologyCellularComponent | dynein complex | 1.60e-03 | 54 | 23 | 2 | GO:0030286 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.66e-03 | 55 | 23 | 2 | GO:0098533 | |
| GeneOntologyCellularComponent | organelle outer membrane | 3.42e-03 | 279 | 23 | 3 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.49e-03 | 281 | 23 | 3 | GO:0019867 | |
| MousePheno | decreased erythrocyte osmotic fragility | 7.83e-05 | 10 | 19 | 2 | MP:0031084 | |
| MousePheno | decreased lung compliance | 9.56e-05 | 11 | 19 | 2 | MP:0010896 | |
| Domain | ABC_transporter_CS | 1.81e-05 | 42 | 23 | 3 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 2.72e-05 | 48 | 23 | 3 | PS50893 | |
| Domain | ABC_tran | 2.72e-05 | 48 | 23 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 2.90e-05 | 49 | 23 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 3.08e-05 | 50 | 23 | 3 | IPR003439 | |
| Domain | ATPase_dyneun-rel_AAA | 1.31e-04 | 14 | 23 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.31e-04 | 14 | 23 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.31e-04 | 14 | 23 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.31e-04 | 14 | 23 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.31e-04 | 14 | 23 | 2 | PF08393 | |
| Domain | MT | 1.31e-04 | 14 | 23 | 2 | PF12777 | |
| Domain | AAA_8 | 1.31e-04 | 14 | 23 | 2 | PF12780 | |
| Domain | AAA_5 | 1.31e-04 | 14 | 23 | 2 | PF07728 | |
| Domain | DHC_fam | 1.51e-04 | 15 | 23 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.51e-04 | 15 | 23 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.51e-04 | 15 | 23 | 2 | PF03028 | |
| Domain | UDPGT | 3.00e-04 | 21 | 23 | 2 | PS00375 | |
| Domain | UDPGT | 3.00e-04 | 21 | 23 | 2 | PF00201 | |
| Domain | UDP_glucos_trans | 3.00e-04 | 21 | 23 | 2 | IPR002213 | |
| Domain | AAA+_ATPase | 7.10e-04 | 144 | 23 | 3 | IPR003593 | |
| Domain | AAA | 7.10e-04 | 144 | 23 | 3 | SM00382 | |
| Domain | - | 1.85e-03 | 746 | 23 | 5 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 3.24e-03 | 848 | 23 | 5 | IPR027417 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.16e-05 | 39 | 20 | 3 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.12e-05 | 44 | 20 | 3 | M45014 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.12e-05 | 44 | 20 | 3 | M11911 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.34e-05 | 45 | 20 | 3 | MM15694 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 5.16e-05 | 52 | 20 | 3 | M14171 | |
| Pathway | WP_CHOLESTASIS | 3.22e-04 | 19 | 20 | 2 | M45520 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 3.22e-04 | 19 | 20 | 2 | M22005 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.51e-04 | 99 | 20 | 3 | MM14986 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.95e-04 | 103 | 20 | 3 | M758 | |
| Pathway | REACTOME_DRUG_ADME | 4.66e-04 | 109 | 20 | 3 | M45012 | |
| Pathway | REACTOME_PREDNISONE_ADME | 4.75e-04 | 23 | 20 | 2 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.18e-04 | 24 | 20 | 2 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 5.63e-04 | 25 | 20 | 2 | MM15820 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.63e-04 | 25 | 20 | 2 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.63e-04 | 25 | 20 | 2 | M605 | |
| Pathway | REACTOME_DRUG_ADME | 6.02e-04 | 119 | 20 | 3 | MM15692 | |
| Pathway | WP_GLUCURONIDATION | 6.09e-04 | 26 | 20 | 2 | M39404 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.57e-04 | 27 | 20 | 2 | M47755 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 7.07e-04 | 28 | 20 | 2 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.52e-03 | 41 | 20 | 2 | M7399 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.67e-03 | 43 | 20 | 2 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.83e-03 | 45 | 20 | 2 | M47670 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.19e-03 | 681 | 20 | 5 | MM14985 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.34e-03 | 51 | 20 | 2 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.71e-03 | 55 | 20 | 2 | M14933 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.08e-03 | 736 | 20 | 5 | M27287 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.66e-03 | 64 | 20 | 2 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.36e-03 | 70 | 20 | 2 | M16794 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 4.61e-03 | 72 | 20 | 2 | M46457 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.61e-03 | 72 | 20 | 2 | M9257 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21679149 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 7904196 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 12111378 | ||
| Pubmed | 7.49e-06 | 193 | 23 | 4 | 19343046 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 26074487 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 9256245 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 32093886 | ||
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 22096573 | ||
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 9373155 | ||
| Pubmed | 9.59e-05 | 22 | 23 | 2 | 8894702 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 1.45e-04 | 27 | 23 | 2 | 18649358 | |
| Pubmed | 2.05e-04 | 32 | 23 | 2 | 20301301 | ||
| Pubmed | 4.44e-04 | 47 | 23 | 2 | 8812413 | ||
| Interaction | UGT2B28 interactions | 1.86e-05 | 6 | 23 | 2 | int:UGT2B28 | |
| Interaction | UGT2B11 interactions | 2.61e-05 | 7 | 23 | 2 | int:UGT2B11 | |
| Cytoband | 4q13.2 | 1.11e-04 | 31 | 23 | 2 | 4q13.2 | |
| Cytoband | 19q13.1 | 3.51e-04 | 55 | 23 | 2 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.80e-03 | 157 | 23 | 2 | chr4q13 | |
| GeneFamily | Dyneins, axonemal | 1.26e-04 | 17 | 18 | 2 | 536 | |
| GeneFamily | UDP glucuronosyltransferases | 4.56e-04 | 32 | 18 | 2 | 363 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-06 | 180 | 23 | 4 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | mild-Platelet|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.02e-06 | 198 | 23 | 4 | 8bb79e749caffb56bee2941594ef2bdc17daba30 | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.58e-05 | 136 | 23 | 3 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.25e-05 | 151 | 23 | 3 | 3dfa1d89975ffaa45b26833538244153d50c60a7 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.25e-05 | 151 | 23 | 3 | 60bb6de5d9b13402bc18cb6d5e51078326dff8e2 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 7.56e-05 | 161 | 23 | 3 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 7.84e-05 | 163 | 23 | 3 | 2dfd11f5803822ba01b92adf4395a3b3adda68f5 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.13e-05 | 165 | 23 | 3 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.13e-05 | 165 | 23 | 3 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 180 | 23 | 3 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 23 | 3 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 23 | 3 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 1.09e-04 | 182 | 23 | 3 | 1a755ea44daf8447a3a1c30de7fdb9c3888bcbde | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 183 | 23 | 3 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | Multiple_Sclerosis-Other-Platelet|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.14e-04 | 185 | 23 | 3 | 2e480dde7ecb2f88ff005f86ef732a1cf0209d45 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 23 | 3 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 186 | 23 | 3 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 186 | 23 | 3 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 186 | 23 | 3 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 186 | 23 | 3 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Healthy/Control-Platelet|World / Disease group and Cell class | 1.20e-04 | 188 | 23 | 3 | 552077e4597d0956f4d8c40c9de8f109e87cb857 | |
| ToppCell | Healthy/Control-Platelet|Healthy/Control / Disease group and Cell class | 1.21e-04 | 189 | 23 | 3 | 3de7f8d8b8451ed9a146cce499552e9a060e9099 | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 1.21e-04 | 189 | 23 | 3 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-04 | 190 | 23 | 3 | b719061be370ffc293854f1f6e526bf33cd2f442 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 1.23e-04 | 190 | 23 | 3 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.23e-04 | 190 | 23 | 3 | 427038bae9c7b3a9441c8d59ace69da74e9d37bf | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-04 | 191 | 23 | 3 | 7da172553ed6df4a0c34ecd55665a9598b5071a5 | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-04 | 191 | 23 | 3 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-04 | 191 | 23 | 3 | 1a1bf85bc77bf093a0ac2cb9eabaeac820a7b93e | |
| ToppCell | mild_COVID-19-Platelet|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.25e-04 | 191 | 23 | 3 | 968e2d48969884dd21b8a87f199af94a7410b0dd | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 1.27e-04 | 192 | 23 | 3 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 23 | 3 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | C_06|World / shred on cell type and cluster | 1.31e-04 | 194 | 23 | 3 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 195 | 23 | 3 | 2a6056172c41c46acfe0242be22269ef1d07921e | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 195 | 23 | 3 | fbfe4a8ae9775764108b45920eec92003b24fb2e | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 195 | 23 | 3 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 195 | 23 | 3 | 0be50d5bd0bef2240f7ace8056ce22a6ca2961b9 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, condition lineage and cell class | 1.35e-04 | 196 | 23 | 3 | 1611920211beb1a3691e3853e0314792a74279a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-04 | 198 | 23 | 3 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | mild-Platelet|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.39e-04 | 198 | 23 | 3 | 91ae3cc261d23ec3aa7656bbf3f13dcbfee262d2 | |
| ToppCell | control-Platelet|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.39e-04 | 198 | 23 | 3 | 1a4b604ef25bd066e870c0d00ee31cde9617f125 | |
| ToppCell | severe-Platelet|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-04 | 199 | 23 | 3 | 6539c197c653fce083a893ac422263abbbc07e79 | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.44e-04 | 200 | 23 | 3 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 200 | 23 | 3 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 200 | 23 | 3 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-04 | 200 | 23 | 3 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | COVID-19-COVID-19_Mild-Others|COVID-19_Mild / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | ecf94be4bb961ec343471547f2ea327bc6f709f4 | |
| ToppCell | MS-Multiple_Sclerosis-Others-Platelet|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | 263d956136747c209951b4358f2e1672a21d8eef | |
| ToppCell | COVID-19-COVID-19_Mild-Others-Platelet|COVID-19_Mild / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | bf5e7a36d6ed44a30f906702b40ace3ecd423398 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-04 | 51 | 23 | 2 | a6f623dba72ce85683e692a68095926e4e71b765 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.91e-04 | 70 | 23 | 2 | c6d3f8cd3f79e2beb826b07a6b9f3ab35d4f23ea | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocye.Tnr.Cspg5_(Cspg5)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.91e-04 | 70 | 23 | 2 | 823921f8bf585d45f24f627b2b77b228898eb85a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.91e-04 | 70 | 23 | 2 | d2be16550c572ba77261c978648e61dba3eab6bd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P3|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.91e-04 | 70 | 23 | 2 | 52bde49a05f2387fe3e4357422e155bee2e86ae6 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.33e-04 | 78 | 23 | 2 | 83d308b15cb3c0820a27b95c8bc85afadf98370e | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.33e-04 | 78 | 23 | 2 | 387e7e07a5a509dc8415a7cb83a2c3940ca1ec85 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Signet-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.10e-04 | 82 | 23 | 2 | 73ddc0286bea35f6d283cea30000a541cc6543c7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.96e-04 | 91 | 23 | 2 | 9c61b9f3e9e4f0c9cb242e313d642c2b75705c88 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.45e-03 | 110 | 23 | 2 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-03 | 116 | 23 | 2 | 1bfd3b0ec4cb5a04c6dfe7861a544eb277e473a3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-03 | 116 | 23 | 2 | a3dcd18807d14e207438f321be62797384fd3907 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-03 | 116 | 23 | 2 | 685484ea4cbefb5aff5f0cd999fdfadc5a5676e1 | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.75e-03 | 121 | 23 | 2 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.81e-03 | 123 | 23 | 2 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.84e-03 | 124 | 23 | 2 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.01e-03 | 130 | 23 | 2 | eb16a8f8f62add5fdd29c78d4608b6d1a06767f1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-03 | 131 | 23 | 2 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.11e-03 | 133 | 23 | 2 | d680c0cf37949aad7bdf04ff5093f005a8c982d6 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.17e-03 | 135 | 23 | 2 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 137 | 23 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 137 | 23 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 2.30e-03 | 139 | 23 | 2 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 140 | 23 | 2 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 140 | 23 | 2 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 140 | 23 | 2 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.36e-03 | 141 | 23 | 2 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 141 | 23 | 2 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 141 | 23 | 2 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.40e-03 | 142 | 23 | 2 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 144 | 23 | 2 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.46e-03 | 144 | 23 | 2 | ce5e219f2548b51440b8b3e1a9f011afd4510d19 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-03 | 145 | 23 | 2 | 1f61987aa7d5fe63004c4a75cb691f83989fc9a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-03 | 146 | 23 | 2 | e887e9de895fd453faa703997ef372cc6410fc49 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-03 | 146 | 23 | 2 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.63e-03 | 149 | 23 | 2 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.63e-03 | 149 | 23 | 2 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-03 | 151 | 23 | 2 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-03 | 151 | 23 | 2 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-03 | 151 | 23 | 2 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | pdx-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.74e-03 | 152 | 23 | 2 | 7ccc56b79c499dd48dab8e2d936edca5223b9356 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.74e-03 | 152 | 23 | 2 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-03 | 152 | 23 | 2 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-03 | 152 | 23 | 2 | aff7d1127ef72be489477611c4decc53cc7632e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-03 | 152 | 23 | 2 | 0a99c91165e4d82fb8825fbdf3071c9a5445669d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-03 | 152 | 23 | 2 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-03 | 152 | 23 | 2 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| Drug | 5 alpha-androstane | 1.45e-06 | 84 | 23 | 4 | CID000094144 | |
| Drug | harmol | 8.68e-06 | 40 | 23 | 3 | CID000068094 | |
| Drug | AC1NQGK1 | 1.93e-05 | 52 | 23 | 3 | CID005195977 | |
| Drug | oxazepam | 2.04e-05 | 53 | 23 | 3 | CID000004616 | |
| Drug | phenobarbital | 2.56e-05 | 360 | 23 | 5 | CID000004763 | |
| Drug | SN-38G | 2.82e-05 | 59 | 23 | 3 | CID000443154 | |
| Drug | acetaminophen glucuronide | 2.82e-05 | 59 | 23 | 3 | CID000083944 | |
| Drug | DMHF | 4.37e-05 | 10 | 23 | 2 | CID003080741 | |
| Drug | sodium cholate | 4.65e-05 | 408 | 23 | 5 | CID000000303 | |
| Drug | Metronidazole | 5.34e-05 | 11 | 23 | 2 | ctd:D008795 | |
| Drug | AC1N8H7N | 6.52e-05 | 78 | 23 | 3 | CID004318740 | |
| Drug | morphine hydrochloride | 1.01e-04 | 481 | 23 | 5 | CID000004253 | |
| Drug | Cholates | 1.32e-04 | 17 | 23 | 2 | ctd:D020355 | |
| Drug | C1 11-32 | 1.48e-04 | 18 | 23 | 2 | CID000443077 | |
| Drug | C11131 | 1.48e-04 | 18 | 23 | 2 | CID000443076 | |
| Drug | Imipenem | 1.48e-04 | 18 | 23 | 2 | ctd:D015378 | |
| Drug | 6-methyl-5H-purine | 1.65e-04 | 19 | 23 | 2 | CID000437029 | |
| Drug | T4-G | 1.65e-04 | 19 | 23 | 2 | CID000152424 | |
| Drug | pheophytin | 1.74e-04 | 284 | 23 | 4 | CID000000250 | |
| Drug | estriol-16-glucuronide | 2.03e-04 | 21 | 23 | 2 | CID000122281 | |
| Drug | lithocholic acid | 2.12e-04 | 116 | 23 | 3 | CID000009903 | |
| Drug | Ex-PRESS | 2.44e-04 | 23 | 23 | 2 | CID000153909 | |
| Drug | estradiol-3-glucuronide | 2.44e-04 | 23 | 23 | 2 | CID000066651 | |
| Drug | kynurenic acid | 2.46e-04 | 122 | 23 | 3 | CID000003845 | |
| Drug | hexobarbital | 2.77e-04 | 127 | 23 | 3 | CID000003608 | |
| Drug | BMS-764459 | 3.13e-04 | 26 | 23 | 2 | ctd:C584056 | |
| Drug | Bi-E | 3.37e-04 | 27 | 23 | 2 | CID006914595 | |
| Drug | oltipraz | 3.46e-04 | 137 | 23 | 3 | CID000047318 | |
| Drug | Menthol | 3.63e-04 | 28 | 23 | 2 | ctd:D008610 | |
| Drug | L-idaro-1,4-lactone | 3.63e-04 | 28 | 23 | 2 | CID000078997 | |
| Drug | fumitremorgin C | 3.63e-04 | 28 | 23 | 2 | CID000403923 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.90e-04 | 29 | 23 | 2 | CID000125641 | |
| Drug | bosentan | 4.17e-04 | 30 | 23 | 2 | ctd:C086232 | |
| Drug | DF 203 | 4.75e-04 | 32 | 23 | 2 | CID000384525 | |
| Drug | BP-3,6-quinol | 5.06e-04 | 33 | 23 | 2 | CID000119292 | |
| Drug | AC1Q6OQG | 5.06e-04 | 33 | 23 | 2 | CID000009686 | |
| Drug | disulfiram | 5.24e-04 | 158 | 23 | 3 | CID000003117 | |
| Drug | AC1LCF1F | 5.54e-04 | 161 | 23 | 3 | CID000627275 | |
| Drug | AC1NOWCJ | 5.69e-04 | 35 | 23 | 2 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.69e-04 | 35 | 23 | 2 | CID010436171 | |
| Drug | estrone-3-glucuronide | 5.69e-04 | 35 | 23 | 2 | CID000115255 | |
| Drug | Diosgenin | 6.02e-04 | 36 | 23 | 2 | ctd:D004144 | |
| Drug | l-borneol | 6.36e-04 | 37 | 23 | 2 | CID000010049 | |
| Drug | AC1Q6S7E | 6.36e-04 | 37 | 23 | 2 | CID000000697 | |
| Drug | glucosiduronate | 6.60e-04 | 171 | 23 | 3 | CID000000610 | |
| Drug | OPC-31260 | 6.71e-04 | 38 | 23 | 2 | CID000119369 | |
| Drug | 4-methylumbelliferyl glucuronide | 6.71e-04 | 38 | 23 | 2 | CID000091553 | |
| Drug | zaleplon | 7.07e-04 | 39 | 23 | 2 | CID000005719 | |
| Drug | Biliton | 7.81e-04 | 41 | 23 | 2 | CID000002974 | |
| Drug | 2-AF | 7.81e-04 | 41 | 23 | 2 | CID000005800 | |
| Drug | testosterone glucuronide | 7.81e-04 | 41 | 23 | 2 | CID000108192 | |
| Drug | SN-38 | 8.16e-04 | 184 | 23 | 3 | CID000104842 | |
| Drug | 3beta-hydroxy-5-spirostene | 8.60e-04 | 43 | 23 | 2 | CID000010536 | |
| Drug | androsterone glucuronide | 8.60e-04 | 43 | 23 | 2 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 8.60e-04 | 43 | 23 | 2 | CID000009191 | |
| Drug | DNCB | 8.82e-04 | 189 | 23 | 3 | CID000000006 | |
| Drug | allodeoxycholic acid | 8.96e-04 | 190 | 23 | 3 | CID000002987 | |
| Drug | 3-isoreserpine | 8.96e-04 | 190 | 23 | 3 | CID000005052 | |
| Drug | Proxyl-opc | 9.00e-04 | 44 | 23 | 2 | CID000124490 | |
| Drug | MS-222 | 9.00e-04 | 44 | 23 | 2 | CID000011400 | |
| Drug | creatine | 9.37e-04 | 193 | 23 | 3 | CID000000586 | |
| Drug | amsacrine | 9.41e-04 | 45 | 23 | 2 | CID000002179 | |
| Drug | dimethylnitrosamine | 9.80e-04 | 196 | 23 | 3 | CID000006124 | |
| Drug | AC1L1KAK | 9.83e-04 | 46 | 23 | 2 | CID000005409 | |
| Drug | 2-butyl-6-methoxyphenol | 9.94e-04 | 197 | 23 | 3 | CID011954184 | |
| Disease | Intrahepatic cholestasis of pregnancy | 6.93e-05 | 16 | 23 | 2 | EFO_0009048 | |
| Disease | phosphatidylcholine 36:4 measurement | 8.82e-05 | 18 | 23 | 2 | EFO_0010382 | |
| Disease | acute myeloid leukemia (is_marker_for) | 6.68e-04 | 49 | 23 | 2 | DOID:9119 (is_marker_for) | |
| Disease | cholestasis (biomarker_via_orthology) | 6.68e-04 | 49 | 23 | 2 | DOID:13580 (biomarker_via_orthology) | |
| Disease | ecosanoids measurement | 8.42e-04 | 55 | 23 | 2 | EFO_0020044 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.17e-03 | 65 | 23 | 2 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.25e-03 | 276 | 23 | 3 | EFO_0004612, EFO_0020943 | |
| Disease | Autism Spectrum Disorders | 1.99e-03 | 85 | 23 | 2 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MFWAGVVFPDMYPWT | 546 | P78363 | |
| LTWGFAFFAWGPMRN | 2951 | Q8IZF6 | |
| QVPWFEQLAQFKMPW | 61 | Q9H221 | |
| MNRFSPAHWVFWVGP | 196 | P55064 | |
| IRFISNPMAPSWWGF | 336 | O15438 | |
| TKVNWPMFPESFGNW | 561 | Q8NBH2 | |
| PQKFYWWFFQTVPGM | 1176 | Q9NRD8 | |
| WIFEGRPNVFWMTGF | 4336 | Q96JB1 | |
| FGIDPQNMFEFWDWV | 256 | P06744 | |
| FFFVQMWSVWDANAP | 291 | P30559 | |
| WVFFQNCHLAPSWMP | 3726 | Q9P2D7 | |
| WENFVYSEGQPFMPW | 156 | Q8IUX4 | |
| SSSQPWEVPFVMWFF | 61 | Q96AP7 | |
| WLPNFMDVFTWSLPF | 351 | P16298 | |
| MPNIFNFMPIRFQWW | 986 | P20648 | |
| GFPWKTSDFMPWNVF | 791 | Q96EK7 | |
| PFAFFGMQAPSIWQW | 106 | P62341 | |
| WFMPVNEGSFPDWER | 601 | Q9C0B6 | |
| WLMRNSWSFQFPHPF | 256 | O75310 | |
| WLMRNSWSFQFPHPF | 256 | Q9BY64 | |
| LNWAWPPIFFGARQM | 91 | P30536 | |
| FWAPFPSWGTMEFPE | 41 | Q9H5J0 | |
| TWWQSPSMAFGVQYP | 101 | Q9Y6N6 |